No significant difference in hospitalization between immunized and non-immunized found for SARS-CoV-2 Beta variant

A study of vaccinated and unvaccinated residents of Bangladesh observed that ChAdOx1 could not prevent the new infection or severe COVID-19 disease outcome with single dose when infections were mostly caused by B.1.351 (the Beta) variants of SARS-CoV2. 

About 39% (n = 42) of the respondents were infected after the COVID-19 vaccination. The first dose of ChAdOx1 nCoV-19 vaccine was received by 40 (37.0%) cases and both doses were completed by only 2 (2%) cases. The average duration between vaccination (partially or completely immunized) and COVID 19 diagnosis was 32 (±17) days. 
The hospitalization rate of comorbid patients was 23.5% among the immunized and 24.1% among the nonimmunized groups. There was no significant difference in duration of hospitalization either (p=0.78). 

Genomic analysis of SARS-CoV-2 variants of concern identified from the ChAdOx1 nCoV-19 immunized patients from Southwest part of Bangladesh


Popular posts from this blog

Fatal COVID-19 Breakthrough Case Following Severe Reaction to ChAdOx1 nCoV-19 Vaccine

COVID-19 Vaccine Injuries including three myocarditis-induced deaths in New Zealand

Octuple-COVID-19-vaccinated politician dies from COVID-19 at 75